VeraBIND Technology:Revolutionizing Early Disease Detection
Transforming Diagnostic Accuracy with VeraBIND
VeraBIND™ technology is at the forefront of early disease detection, particularly in challenging sample types. At its core, this innovative technology is designed to transform complex samples into matrix-free samples, significantly enhancing the performance of current market tests. It delivers unmatched precision in biomarker detection, empowering researchers and healthcare professionals to advance diagnostics and improve patient outcomes. VeraBIND is setting new standards in the field of biomarker enrichment and early disease detection.
Key Features of VeraBIND Technology
- Uniform Size Magnetic Nanobeads
Improves reproducibility, precision, and binding capacity for more reliable results
- Rapid Magnetic Separation
Enables automation and reduces process times, enhancing laboratory efficiency
- Hydrophilic Surface Layer
- Improved Assay Accuracy
Pre-analytically cleans and conditions the sample to help improve the accuracy of assays that are challenged by interferences
How is Alzheimer's Disease Detected?
Improving Diagnostic Accuracy
Facilitating Early Disease Detection
Supports early diagnostic tests to identify diseases at their initial stages, especially in conditions where early intervention can significantly alter the disease’s progression.
Contributes to personalized medicine by identifying specific biomarkers, aiding in the development of tailored treatments for individual patients.
Perform Liquid Biopsies
Enhancing Clinical Diagnostics & Research
A Comprehensive Solution for Biomarker Detection
VeraBIND technology offers a unique and comprehensive approach, improving the accuracy of biomarker detection and reducing the incidence of false results. This groundbreaking innovation allows clinical laboratories to minimize assay interferences and refine their diagnostic processes, contributing significantly to early disease detection and enabling timely, targeted interventions.
VeraBIND was used to develop the VeraBIND Tau assay, a groundbreaking blood test for early detection of Alzheimer’s Disease tau pathology. By eliminating interference from plasma samples and capturing and purifying biomarkers such as hyperphosphorylated tau (HPT), VeraBIND provides a more accurate and sensitive diagnostic approach. Our proprietary technology and product solutions makes Veravas a leader in non-invasive diagnostic solutions.
VeraBIND Technology Products
VeraBIND™Clean Beads Kit
Designed to improve immunoassay quality by removing diverse endogenous human immunoglobulin interferences from serum, plasma, saliva, or saline oral rinse samples.
VeraBIND™Streptavidin Beads for Free Biotin Depletion Kit
Precisely engineered to eliminate free biotin and anti-streptavidin interference, enhancing immunoassay accuracy and reliability.
VeraBIND™Streptavidin Beads Protein Coating Kit
VeraBIND™Biomarker Purification Kit
A versatile tool designed to capture, clean, and purify biomarkers from serum, plasma, saliva, or saline oral rinse samples.
VeraBIND™Antibody Detection Kit
VeraBIND™Borrelia Antibody Assay
VeraBIND™tTG Antibody Assay
A bead-based fluorescent immunoassay enabling multiplex detection of total IgA and IgG antibodies against human tissue transglutaminase (tTG) which can be used to help diagnose celiac disease.